Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2007
-
By Donald Zuhn — As Patent Docs reported yesterday, Codon Devices, Inc., Duke University, and the Massachusetts Institute of Technology filed suit against Blue Heron Biotechnology on March 14th, asserting that Blue Heron’s manufacture and use of the GeneMaker® gene synthesis platform infringes plaintiffs’ U.S. Patent Nos. 5,459,039; 5,556,750; 5,679,522; 5,702,894; and 5,750,335…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Oklahoma Medical Research Foundation v. Alexion Pharmaceuticals, Inc.4:07-cv-00163; filed March 15, 2007 in the Northern District of Oklahoma Infringement of U.S. Patent…
-
By Christopher P. Singer — Patent Docs was given the opportunity to review a recently-published book by patent attorney M. Henry Heines, Ph.D., titled "Patents for Business: The Manager’s Guide to Scope, Strategy, and Due Diligence" (Praeger Publishers, Westport, CT (2007)). In his text, Dr. Heines provides an easy-to-read overview of intellectual property…
-
March 21-22, 2007 – Complex IP & Technology Transactions Conference (Law Seminars International) – Chicago, IL March 25-29, 2007 – American Chemical Society National Meeting – Chicago, IL April 16-18, 2007 – Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman (Patent Resources Group) – Orlando, FL April 27, 2007 – Patent Claim Construction Workshop (Law Seminars…
-
By Donald Zuhn — Earlier this month, we reported that the PricewaterhouseCoopers 2007 Patent and Trademark Damages Study showed that patent actions had dropped more than 11% in 2005. The Intellectual Property Owners Association (IPO) reported today that data released this week from the Administrative Office of the U.S. Courts indicates that after…
-
By Christopher P. Singer — Angiotech® announced in a March 15, 2007 press release that the European Patent Office’s Technical Board of Appeal denied Conor Medsystems Inc.’s and Sahajanand Medical Technologies Pvt. Ltd.’s request to intervene and appeal a prior ruling by the Opposition Division of the EPO regarding Angiotech’s "Hunter" patent (EP…
-
By Donald Zuhn — Oxford BioMedica announced on March 12th that it has entered into an agreement to acquire Oxxon Therapeutics Ltd. The transaction – valued at about US $31 million – will be completed, in part, by the issuance of more than 27 million Oxford BioMedica shares to Oxxon shareholders. Oxford BioMedica…
-
By Mark Chael — On February 21, 2007, the Board of Patent Appeals and Interferences (BPAI) at the U.S. Patent and Trademark Office (USPTO) entered judgment in favor of Enzo Life Sciences, a subsidiary of Enzo Biochem, Inc., after Princeton University and Imclone Systems, Inc. requested adverse judgment in a prior filing in…
-
By Jason Derry — Abbott Laboratories has announced that it will no longer launch new medicines in Thailand. In addition, Abbott has decided to withdraw its current applications for medicines in Thailand. The decision is based on Thailand’s recent decision to issue compulsory licenses for Abbott’s AIDS drug Kaletra, and the failure to…
-
By Donald Zuhn — The United States Patent and Trademark Office recently issued U.S. Patent No. 7,179,484 to Azaya Therapeutics, Inc. The ‘484 patent, which relates to protein-stabilized liposomal formulations for the delivery of pharmaceutical agents, is the first U.S. patent to be awarded to the San Antonio-based pharmaceutical company. After receiving a…
Patent Docs 